Stock Track | Moderna Soars 10.76% as Jefferies Suggests 'Peak RFK Negativity' May Have Been Reached

Stock Track01:04

Moderna, Inc. (MRNA) stock surged 10.76% in Friday's intraday trading session as Jefferies analysts expressed optimism that the negative sentiment surrounding the company's COVID vaccine liability and Robert F. Kennedy Jr.'s criticisms may have peaked.

During a fireside meeting with Moderna's management, Jefferies noted that the company addressed concerns over the lack of COVID vaccine mandates and the potential impact on demand. Moderna reassured investors that there is still significant demand for updated booster shots, particularly in the over-65 age group.

Jefferies analysts believe that the market may have reached the "peak RFK negativity," referring to the intense scrutiny and criticism from Robert F. Kennedy Jr., a prominent anti-vaccine activist. Moderna's management acknowledged the challenges posed by the negative publicity but remains confident in their ability to navigate the situation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1156849263?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-23 01:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156849263","market":"hk","top_or_hot":-1,"title":"Stock Track | Moderna Soars 10.76% as Jefferies Suggests 'Peak RFK Negativity' May Have Been Reached","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) stock surged 10.76% in Friday's intraday trading session as Jefferies analysts expressed optimism that the negative sentiment surrounding the company's COVID vaccine liability and Robert F. Kennedy Jr.'s criticisms may have peaked.</p>\n\n<p>During a fireside meeting with Moderna's management, Jefferies noted that the company addressed concerns over the lack of COVID vaccine mandates and the potential impact on demand. Moderna reassured investors that there is still significant demand for updated booster shots, particularly in the over-65 age group.</p>\n\n<p>Jefferies analysts believe that the market may have reached the \"peak RFK negativity,\" referring to the intense scrutiny and criticism from Robert F. Kennedy Jr., a prominent anti-vaccine activist. Moderna's management acknowledged the challenges posed by the negative publicity but remains confident in their ability to navigate the situation.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Soars 10.76% as Jefferies Suggests 'Peak RFK Negativity' May Have Been Reached</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Soars 10.76% as Jefferies Suggests 'Peak RFK Negativity' May Have Been Reached\n</h2>\n\n<h4 class=\"meta\">\n\n2024-11-23 01:04 北京时间&nbsp;&nbsp;&nbsp;<strong>Stock Track</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna, Inc. (MRNA) stock surged 10.76% in Friday's intraday trading session as Jefferies analysts expressed optimism that the negative sentiment surrounding the company's COVID vaccine liability and...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1156849263","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156849263","pubTimestamp":1732295062,"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc.  stock surged 10.76% in Friday's intraday trading session as Jefferies analysts expressed optimism that the negative sentiment surrounding the company's COVID vaccine liability and Robert F. Kennedy Jr.'s criticisms may have peaked.During a fireside meeting with Moderna's management, Jefferies noted that the company addressed concerns over the lack of COVID vaccine mandates and the potential impact on demand. Moderna reassured investors that there is still significant demand for up","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"杰富瑞(Jefferies)表示“RFK负面情绪可能已达到峰值”，Moderna股价飙升10.76%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) stock surged 10.76% in Friday's intraday trading session as Jefferies analysts expressed optimism that the negative sentiment surrounding the company's COVID vaccine liability and Robert F. Kennedy Jr.'s criticisms may have peaked.\nDuring a fireside meeting with Moderna's management, Jefferies noted that the company addressed concerns over the lack of COVID vaccine mandates and the potential impact on demand. Moderna reassured investors that there is still significant demand for updated booster shots, particularly in the over-65 age group.\nJefferies analysts believe that the market may have reached the \"peak RFK negativity,\" referring to the intense scrutiny and criticism from Robert F. Kennedy Jr., a prominent anti-vaccine activist. Moderna's management acknowledged the challenges posed by the negative publicity but remains confident in their ability to navigate the situation.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1156849263"}